Valuation: MindWalk Holdings Corp.

Market Cap 104M 74M 64.7M 59.69M 54.87M 7.12B 106M 713M 280M 3.48B 278M 272M 12B P/E 2026 *
-6.65x
P/E 2027 * -7.99x
Enterprise Value 104M 74M 64.7M 59.69M 54.87M 7.12B 106M 713M 280M 3.48B 278M 272M 12B EV / Sales 2026 *
6.55x
EV / Sales 2027 * 5.08x
Free-Float
90.98%
Yield 2026 *
-
Yield 2027 * -
1 day+0.68%
1 week+3.47%
Current month-5.70%
1 month-4.49%
3 months+16.41%
6 months-25.50%
Current year-18.13%
1 week 1.36
Extreme 1.361
1.52
1 month 1.36
Extreme 1.361
1.7
Current year 0.99
Extreme 0.99
2.99
1 year 0.99
Extreme 0.99
3.25
3 years 0.27
Extreme 0.27
3.25
5 years 0.27
Extreme 0.27
16.47
10 years 0.27
Extreme 0.27
33.34
Manager TitleAgeSince
Chief Executive Officer - 2018-02-20
Director of Finance/CFO 62 2025-10-19
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2018-05-23
Chairman - -
Director/Board Member 56 2025-07-06
Date Insider Type Main position Quantity % Market Cap.
03-29Buy

Chief Financial Officer

26,500 0.0574%
03-29Other

Executive/Senior Manager

0 0%
03-29Buy

Executive/Senior Manager

20,000 0.0433%
Change 5-day change 1-year change 3-year change Capi.($)
+0.68%+3.47%-18.13%-47.16% 74M
+1.27%+0.24%+21.26%-7.53% 67.6B
-0.42%-6.12%+38.34%+192.79% 51.32B
+1.10%+38.30%+38.30%+38.30% 42.97B
+0.16%-2.85%-50.72%-52.88% 40.81B
+2.76%-1.56%+54.70%-29.29% 29.12B
+1.25%-7.48%+116.21%-43.73% 27.09B
+0.18%-1.85%+68.63%+86.35% 22.99B
-2.94%+9.09%+9.28%+199.05% 21.55B
+3.79%-0.71%+67.99%+131.00% 16.38B
Average +0.78%-0.20%+34.59%+46.69% 31.99B
Weighted average by Cap. +0.74%-0.77%+33.17%+47.68%

Financials

2026 *2027 *
Net sales 15.88M 11.3M 9.88M 9.11M 8.38M 1.09B 16.15M 109M 42.7M 532M 42.44M 41.51M 1.83B 20.47M 14.57M 12.74M 11.75M 10.8M 1.4B 20.82M 140M 55.05M 685M 54.72M 53.52M 2.36B
Net income -14.29M -10.17M -8.89M -8.2M -7.54M -979M -14.53M -97.94M -38.43M -478M -38.2M -37.36M -1.65B -12M -8.54M -7.47M -6.89M -6.33M -822M -12.21M -82.27M -32.28M -402M -32.09M -31.38M -1.39B
Net Debt - -
Logo MindWalk Holdings Corp.
MindWalk Holdings Corp., formerly ImmunoPrecise Antibodies Ltd., is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, the Company unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
Employees
92
Date Price Change Volume
26-07-15 US$1.490 +0.68% 167,330
26-07-14 US$1.480 +4.96% 193,901
26-07-13 US$1.410 -1.40% 155,698
26-07-10 US$1.430 -2.05% 140,326
26-07-09 US$1.460 +1.39% 104,490
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.490USD
Average target price
4.333USD
Spread / Average Target
+190.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HYFT Stock